Browsing Tag
Denmark
121 posts
Galecto Biotech secures €79m in Series C funding to advance idiopathic pulmonary fibrosis treatment
Galecto Biotech, a Denmark-based pharmaceutical company specializing in galectin modulators for severe diseases like idiopathic pulmonary fibrosis (IPF)…
October 27, 2018
Syneron Candela acquires Danish medical device company Ellipse
Medical industry news : Syneron Candela, a US-based aesthetic device company, has announced the acquisition of Danish medical…
September 15, 2018
LEO Pharma secures global rights to JW1601 in $402m deal with JW Pharmaceutical
LEO Pharma, a leading Danish pharmaceutical company, has acquired global exclusive rights to the atopic dermatitis drug JW1601…
August 27, 2018
Novo Nordisk acquires Ziylo in $800m deal to advance diabetes treatment
Novo Nordisk, a leading Danish pharmaceutical company, has completed a significant acquisition of Ziylo, a biotechnology spin-out from…
August 24, 2018
Danish Crown acquires Danish pepperoni topping producer DK-Foods
Food acquisition news : Meat processing company Danish Crown has acquired DK-Foods, a Danish pepperoni topping producer which…
March 20, 2018
Lundbeck to acquire Prexton Therapeutics in $1.1bn deal to expand Parkinson’s Disease treatment portfolio
Lundbeck, a leading Danish pharmaceutical company, has announced its acquisition of Prexton Therapeutics, a Swiss firm specializing in…
March 16, 2018
Orkla acquires Danish bakery company Struer Brod
Food acquisition news : Norwegian conglomerate Orkla has purchased Danish bakery company Struer Brod for an undisclosed price…
February 5, 2018
Maersk Oil, partners to move ahead with $3.4bn Tyra redevelopment project
Oil and gas industry news : Maersk Oil and its partners as part of the Danish Underground Consortium…
December 2, 2017
Danish Crown subsidiary takes stake in South African foodservice company
Food acquisition news : ESS-Food, a subsidiary of Danish food processing company Danish Crown, has struck an agreement…
November 25, 2017
FDA approves Novo Nordisk’s Victoza for cardiovascular disease treatment in type 2 diabetes patients
Novo Nordisk’s diabetes medication, Victoza (liraglutide), has gained U.S. Food and Drug Administration (FDA) approval for an expanded…
August 26, 2017